This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Naritaka Tamaoki: Innovator in Hematopoietic Progenitor Cell Research
Introduction
Naritaka Tamaoki is a notable inventor based in North Bethesda, MD (US). He has made significant contributions to the field of hematopoietic progenitor cell research. His innovative work has implications for treating various conditions, including cancer.
Latest Patents
Tamaoki holds a patent for "Methods of preparing hematopoietic progenitor cells in vitro." This patent discloses methods for preparing CD34+CD43+ hematopoietic progenitor cells (HPC) in vitro. It also includes methods for differentiating these progenitor cells into hematopoietic lineage cells. Furthermore, the patent outlines methods for treating or preventing conditions in mammals, such as cancer.
Career Highlights
Tamaoki is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to focus on groundbreaking research in cell biology and regenerative medicine.
Collaborations
Some of his notable coworkers include Raul E Vizcardo and Meghan L Good. Their collaborative efforts contribute to the advancement of research in hematopoietic progenitor cells.
Conclusion
Naritaka Tamaoki's contributions to the field of hematopoietic progenitor cell research are invaluable. His innovative methods and dedication to advancing medical science highlight the importance of research in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile